VUMC News and Communications

David Merryman, associate professor of biomedical engineering, found that a drug developed for rheumatoid arthritis stops a common binding protein from calcifying heart valves. (Vanderbilt University)

Drug developed for arthritis could be first to stop heart valve calcification

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.

By VUMC News and Communications

Repriming replication roadblocks

New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away.

Flip side of gut protection

Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.

Research participants sought: Parents, children and the effects of stress

Your family may be eligible to participate in a research study at Vanderbilt University that aims to help parents and children regarding the effects of stress.

By VUMC News and Communications

VUSM joins initiative to transform medical education

Vanderbilt University School of Medicine (VUSM) has been chosen to be a part of the newly formed Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education (Kern Institute), a national initiative to transform medical education across the continuum from pre-medical school to physician practice.